Cargando…
Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence
Mcl-1, a Bcl-2 family member, is highly expressed in a variety of human cancers and is believed to enhance tumorigenic potential and chemotherapy resistance through the inhibition of apoptosis and senescence. We previously reported that Mcl-1′s regulation of chemotherapy-induced senescence (CIS) is...
Autores principales: | Demelash, Abeba, Pfannenstiel, Lukas W., Liu, Li, Gastman, Brian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438639/ https://www.ncbi.nlm.nih.gov/pubmed/28423654 http://dx.doi.org/10.18632/oncotarget.15962 |
Ejemplares similares
-
Raiding the pharmacy: genomic screening identifies known chemotherapies as negative
regulators of MCL1
por: Pfannenstiel, Lukas W, et al.
Publicado: (2012) -
Mcl-1 and tumor cell persistence
por: Pfannenstiel, Lukas W., et al.
Publicado: (2014) -
Mcl-1 expression influcences CD8+ anti-tumor immunity.
por: Pfannenstiel, Lukas W, et al.
Publicado: (2015) -
MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
por: Fu, Dechen, et al.
Publicado: (2022) -
Nox, Reactive Oxygen Species and Regulation of Vascular Cell Fate
por: Burtenshaw, Denise, et al.
Publicado: (2017)